Rh-Hr Blood-Group SystemDiabetic AngiopathiesCoronary VesselsCoronary DiseaseDiabetes MellitusHeartDiabetes Mellitus, Type 1Coronary AngiographyCoronary Artery DiseaseDiabetes Mellitus, Type 2Coronary CirculationRisk FactorsDiabetes Mellitus, ExperimentalDiabetes ComplicationsAngioplasty, Balloon, CoronaryDiabetic RetinopathyDiabetic NephropathiesCoronary StenosisCoronary Artery BypassHeart RateMyocardial InfarctionBlood GlucoseProspective StudiesFollow-Up StudiesHeart FailureCoronary VasospasmTime FactorsCohort StudiesDiabetic FootInsulinHemoglobin A, GlycosylatedPregnancy in DiabeticsRisk AssessmentCoronary AneurysmHeart DiseasesCardiovascular DiseasesTreatment OutcomeCoronary ThrombosisHypoglycemic AgentsIncidenceBiological MarkersMyocardial IschemiaStreptozocinCoronary RestenosisPredictive Value of TestsCase-Control StudiesCholesterolCholesterol, HDLCholesterol, LDLPrevalenceProportional Hazards ModelsDiabetes, GestationalRiskHyperglycemiaBlood PressureHeart TransplantationCoronary OcclusionLipidsMyocardiumHypertensionSex FactorsAge FactorsPercutaneous Coronary InterventionUnited StatesRetrospective StudiesElectrocardiographyCoronary Care UnitsCalcinosisTriglyceridesObesityCross-Sectional StudiesHeart Defects, CongenitalHypercholesterolemiaSmokingHemodynamicsBody Mass IndexMultivariate AnalysisOdds RatioAlbuminuriaPrognosisReference ValuesLogistic ModelsRegression AnalysisDiabetic CardiomyopathiesDogsHyperlipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsC-Reactive ProteinSeverity of Illness IndexJapanEndothelium, VascularVasodilator AgentsInsulin ResistanceStrokeStentsVasodilationGlucose Tolerance TestAnticholesteremic AgentsFinland